Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients.

doi:10.1097/MD.0000000000010419

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients.

Medicine - 1 Apr 2018

Owen Gareth I, Pinto Mauricio P, Retamal Ignacio N, Fernádez María F, Cisternas Betzabe, Mondaca Sebastian, Sanchez Cesar, Galindo Hector, Nervi Bruno, Ibañez Carolina, Acevedo Francisco, Madrid Jorge, Peña José, Bravo Maria Loreto, Maturana Maria Jose, Cordova-Delgado Miguel, Romero Diego, de la Jara Nathaly, Torres Javiera, Rodriguez-Fernandez Maria, Espinoza Manuel, Balmaceda Carlos, Freire Matías, Gárate-Calderón Valentina, Crovari Fernando, Jimenez-Fonseca Paula, Carmona-Bayonas Alberto, Zwenger Ariel, Armisen Ricardo, Corvalan Alejandro H, Garrido Marcelo

Abstract excerpt

Gastric cancer (GC) is the world's second-leading cause of neoplastic mortality. Genetic alterations, response to treatments, and mortality rates are highly heterogeneous across different regions. Within Latin America, GC is the leading cause of cancer death in Chile, affecting 17.6 per 100,000 people and causing >3000 deaths/y. Clinical outcomes and response to "one size fits all" therapies are highly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chile

Share to DNA Methylation

Share to Herpesvirus 4, Human

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Stomach Neoplasms

Share to Tissue Array Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 29668600
DOI: 10.1097/MD.0000000000010419
PMCID: PMC5916646

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients.PMID 29668600Read ↗

High Proportion of Potential Candidates for Immunotherapy in a Chilean Cohort of Gastric Cancer Patients: Results of the FORCE1 StudySemantic proximity Read ↗

Proposed Molecular and miRNA Classification of Gastric Cancer.Semantic proximity Read ↗

Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment StrategiesSemantic proximity Read ↗

The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.Semantic proximity Read ↗

Evolving Molecular Subtypes of Gastric Cancer: From Past Classifications to Present Consensus and Future Directions for Precision TherapySemantic proximity Read ↗

[Update on gastric cancer. New molecular classifications].Semantic proximity Read ↗

Translating gastric cancer genomics into targeted therapiesSemantic proximity Read ↗

Molecular Profiling of Gastric Cancer: Toward Personalized Cancer MedicineSemantic proximity Read ↗

Molecular classification of gastric cancer.Semantic proximity Read ↗

Molecular Pathology of Gastric CancerSemantic proximity Read ↗

Identifying gastric cancer molecular subtypes by integrating DNA-based hierarchical classification strategy and clinical stratificationSemantic proximity Read ↗

Personalized medicine in gastric cancer: Where are we and where are we going?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.